CONFERENCES

    Global Tobacco & Nicotine Forum

    The Global Tobacco & Nicotine Forum (GTNF) is an annual global event that brings together stakeholders from across the tobacco and nicotine industries to discuss the future, current issues, trends and opportunities. The forum provides a platform for industry leaders, researchers, policymakers, and advocates to engage in a dialogue about the challenges and opportunities facing the tobacco and nicotine sectors. Topics discussed include the latest developments in public health policy, scientific research on tobacco and nicotine products (such as e-cigarettes, heated tobacco products etc.), and market trends. The GTNF is known for its informative presentations, dynamic dialogues and networking opportunities, making it a valuable forum that we often attend.

    12th GTNF Forum 2021

    Date

    Sep 21, 2021 - Sep 23, 2021

    Location

    London, U.K.

    Online

    This forum, which has for theme "Continuing Change: Innovation & Sustainability", aims to explore new trends in industry development and find new value for industry changes.

    7th GTNF Forum 2016

    Date

    Sep 27, 2016 - Sep 29, 2016

    Location

    Brussels, Belgium

    This event includes a plenary panel discussion with Germana Barba, PMI's director of corporate affairs and reduced-risk products, on 'Advancing public health with new products and regulatory frameworks'.

    See related presentations

    6th GTNF Forum 2015

    Date

    Sep 15, 2015 - Sep 17, 2015

    Location

    Bologna, Italy

    This meeting includes presentations by PMI scientists on the assessment of Heat-not-Burn products and the regulatory path for reduced-risk products.

    See related presentations

    PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
    ​
    Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.